Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
종목 코드 CODX
회사 이름Co-Diagnostics Inc
상장일Jul 12, 2017
CEOMr. Dwight H. Egan
직원 수132
유형Ordinary Share
회계 연도 종료Jul 12
주소2401 S. Foothill Dr. Suite D
도시SALT LAKE CITY
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호84109
전화18014381036
웹사이트http://codiagnostics.com/
종목 코드 CODX
상장일Jul 12, 2017
CEOMr. Dwight H. Egan
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음